K.J. Harrison & Partners Inc Takes $1.25 Million Position in Henry Schein, Inc. $HSIC

K.J. Harrison & Partners Inc bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 17,000 shares of the company’s stock, valued at approximately $1,253,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Praxis Investment Management Inc. acquired a new position in shares of Henry Schein during the first quarter valued at about $282,000. PFG Investments LLC acquired a new stake in shares of Henry Schein in the 1st quarter valued at about $202,000. MQS Management LLC bought a new stake in Henry Schein in the 1st quarter valued at about $310,000. Pictet Asset Management Holding SA increased its position in Henry Schein by 3.1% in the 1st quarter. Pictet Asset Management Holding SA now owns 23,263 shares of the company’s stock valued at $1,714,000 after buying an additional 696 shares in the last quarter. Finally, Foster & Motley Inc. raised its stake in Henry Schein by 28.2% during the 1st quarter. Foster & Motley Inc. now owns 6,098 shares of the company’s stock worth $449,000 after buying an additional 1,342 shares during the period. 96.62% of the stock is owned by institutional investors.

Insider Activity

In other news, Director William K. Daniel bought 10,000 shares of Henry Schein stock in a transaction dated Monday, May 11th. The stock was purchased at an average price of $69.19 per share, for a total transaction of $691,900.00. Following the purchase, the director directly owned 20,000 shares in the company, valued at $1,383,800. The trade was a 100.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.89% of the stock is currently owned by insiders.

Henry Schein Stock Performance

Shares of HSIC opened at $86.43 on Friday. The firm has a market capitalization of $9.85 billion, a P/E ratio of 26.11, a P/E/G ratio of 1.67 and a beta of 0.81. Henry Schein, Inc. has a 52 week low of $61.94 and a 52 week high of $89.29. The stock has a 50 day moving average price of $77.20 and a two-hundred day moving average price of $77.07. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.75 and a current ratio of 1.36.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.12. The business had revenue of $3.37 billion during the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.Henry Schein’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities analysts forecast that Henry Schein, Inc. will post 5.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Mizuho cut their price target on Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. UBS Group reaffirmed a “neutral” rating and set a $85.00 target price (down from $87.00) on shares of Henry Schein in a research report on Wednesday, May 6th. Robert W. Baird set a $97.00 target price on Henry Schein in a report on Wednesday, May 6th. Weiss Ratings reissued a “hold (c+)” rating on shares of Henry Schein in a research report on Monday, May 4th. Finally, Wall Street Zen lowered shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $87.85.

Henry Schein Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.